Skip to main content
Top
Published in: Familial Cancer 2/2017

Open Access 01-04-2017 | Original Article

Pain evaluation during gynaecological surveillance in women with Lynch syndrome

Authors: Jorien Helder-Woolderink, Geertruida de Bock, Harry Hollema, Magda van Oven, Marian Mourits

Published in: Familial Cancer | Issue 2/2017

Login to get access

Abstract

To evaluate perceived pain during repetitive annual endometrial sampling at gynaecologic surveillance in asymptomatic women with Lynch syndrome (LS) over time and in addition to symptomatic women without LS, undergoing single endometrial sampling. In this prospective study, 52 women with LS or first degree relatives who underwent repetitive annual gynaecological surveillance including endometrial sampling of which 33 were evaluated twice or more and 50 symptomatic women without LS who had single endometrial sampling, were included. Pain intensity was registered with VAS scores. Differences in pain intensities between subsequent visits (in LS) and between the two groups were evaluated. The use of painkillers before endometrial sampling was registered. If women with LS decided for preventive surgery, the reason was recorded. The LS group reported a median VAS score of 5.0 (range 0–10) at the first surveillance (n = 52) and at the second visit (n = 24). Women who repeatedly underwent endometrial sampling more often used painkillers for this procedure. During the study period 7/52 (13 %) women with LS choose for preventive surgery, another 4/52 (8 %) refused further endometrial sampling. Painful endometrial sampling was mentioned as main reason to quit screening. The median VAS score of the 50 symptomatic women was 5.0 (range 1–9). Endometrial sampling, irrespective of indication, is a painful procedure, with a median VAS score of 5.0. During subsequent procedures in women with LS, the median pain score does not aggravate although one in five women chose an alternative for endometrial sampling.
Literature
1.
go back to reference Renkonen-Sinisalo L, Butzow R, Leminen A, Lehtovirta P, Mecklin JP, Jarvinen HJ (2006) Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 120(4):821–824CrossRef Renkonen-Sinisalo L, Butzow R, Leminen A, Lehtovirta P, Mecklin JP, Jarvinen HJ (2006) Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 120(4):821–824CrossRef
2.
go back to reference Quehenberger F, Vasen HF, Van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42:491–496CrossRefPubMedPubMedCentral Quehenberger F, Vasen HF, Van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42:491–496CrossRefPubMedPubMedCentral
3.
go back to reference Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ (2007) Society of Gynecologic Oncologists Education Committee. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107(2):159–162CrossRefPubMed Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ (2007) Society of Gynecologic Oncologists Education Committee. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107(2):159–162CrossRefPubMed
4.
go back to reference Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD et al (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135(2):419–428CrossRefPubMedPubMedCentral Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD et al (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135(2):419–428CrossRefPubMedPubMedCentral
5.
go back to reference Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB et al (2010) Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102:193–201CrossRefPubMedPubMedCentral Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB et al (2010) Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102:193–201CrossRefPubMedPubMedCentral
6.
go back to reference Moldovan R, Keating S, Clancy T (2015) The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. Fam Cancer 14(1):51–60CrossRefPubMed Moldovan R, Keating S, Clancy T (2015) The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. Fam Cancer 14(1):51–60CrossRefPubMed
7.
go back to reference Koornstra JJ, Mourits MJE, Sijmons RH, Leliveld AM, Hollema HH, Kleibeuker JH (2009) Management of extra-colonic tumours in patients with Lynch syndrome. Lancet Oncol 10(4):400–408CrossRefPubMed Koornstra JJ, Mourits MJE, Sijmons RH, Leliveld AM, Hollema HH, Kleibeuker JH (2009) Management of extra-colonic tumours in patients with Lynch syndrome. Lancet Oncol 10(4):400–408CrossRefPubMed
8.
go back to reference Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb P et al (2010) Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer 127(11):2678–2684CrossRefPubMedPubMedCentral Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb P et al (2010) Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer 127(11):2678–2684CrossRefPubMedPubMedCentral
9.
go back to reference Tzortzatos G, Andersson E, Soller M, Stenmark Askmalm M, Zagoras T, Georgii-Hemming P, Lindblom A, Tham E, Mirts M (2015) The gynecological surveillance of women with Lynch syndrome in Sweden. Gynecol Oncol 138(3):717–722CrossRefPubMed Tzortzatos G, Andersson E, Soller M, Stenmark Askmalm M, Zagoras T, Georgii-Hemming P, Lindblom A, Tham E, Mirts M (2015) The gynecological surveillance of women with Lynch syndrome in Sweden. Gynecol Oncol 138(3):717–722CrossRefPubMed
10.
go back to reference Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Bernstein I, Bertario L, Burn J, Capella G, Colas C, Engel C, Frayling IM, Genuardi M, Heinimann K, Hes FJ, Hodgson SV, Karagiannis JA, Lalloo F, Lindblom A, Mecklin JP, Møller P, Myrhoj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Sijmons RH, Tejpar S, Thomas HJ, Rahner N, Wijnen JT, Järvinen HJ, Möslein G, Mallorca group (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62(6):812–823CrossRefPubMedPubMedCentral Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Bernstein I, Bertario L, Burn J, Capella G, Colas C, Engel C, Frayling IM, Genuardi M, Heinimann K, Hes FJ, Hodgson SV, Karagiannis JA, Lalloo F, Lindblom A, Mecklin JP, Møller P, Myrhoj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Sijmons RH, Tejpar S, Thomas HJ, Rahner N, Wijnen JT, Järvinen HJ, Möslein G, Mallorca group (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62(6):812–823CrossRefPubMedPubMedCentral
11.
go back to reference Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, van der Zee AG (2003) Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 91(1):74–80CrossRefPubMed Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, van der Zee AG (2003) Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 91(1):74–80CrossRefPubMed
12.
go back to reference Helder-Woolderink JM, De Bock GH, Sijmons RH, Hollema H, Mourits MJ (2013) The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome. Gynecol Oncol 131(2):304–308CrossRefPubMed Helder-Woolderink JM, De Bock GH, Sijmons RH, Hollema H, Mourits MJ (2013) The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome. Gynecol Oncol 131(2):304–308CrossRefPubMed
14.
go back to reference Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Nustad K (1996) Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 103(8):826–831CrossRefPubMed Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Nustad K (1996) Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 103(8):826–831CrossRefPubMed
15.
go back to reference Elmasry K, Davies AJ, Evans DG, Seif MN, Reynolds K (2009) Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study. Fam Cancer 8(4):431–439CrossRefPubMed Elmasry K, Davies AJ, Evans DG, Seif MN, Reynolds K (2009) Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study. Fam Cancer 8(4):431–439CrossRefPubMed
16.
go back to reference Schmeler KM, Lynch HT, Chen L, Munsell MF, Soliman PT, Clark MB et al (2006) Prophylactic surgery to reduce the risk of gynaecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269CrossRefPubMed Schmeler KM, Lynch HT, Chen L, Munsell MF, Soliman PT, Clark MB et al (2006) Prophylactic surgery to reduce the risk of gynaecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269CrossRefPubMed
17.
go back to reference Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB (2007) Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol 110(1):18–25CrossRefPubMed Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB (2007) Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol 110(1):18–25CrossRefPubMed
18.
go back to reference Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF, Lynch PM (2014) Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome. Gynecol Oncol 135(1):85–89CrossRefPubMedPubMedCentral Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF, Lynch PM (2014) Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome. Gynecol Oncol 135(1):85–89CrossRefPubMedPubMedCentral
19.
go back to reference Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K (2011) Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract 7(1):43–47CrossRefPubMedPubMedCentral Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K (2011) Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract 7(1):43–47CrossRefPubMedPubMedCentral
20.
go back to reference Somchit W, Lertkhachonsuk AA, Vallipakorn SA (2015) Naproxen for pain relief during endometrial biopsy: a randomized controlled trial. J Med Assoc Thail 98(7):631–635 Somchit W, Lertkhachonsuk AA, Vallipakorn SA (2015) Naproxen for pain relief during endometrial biopsy: a randomized controlled trial. J Med Assoc Thail 98(7):631–635
21.
go back to reference Frey MK, David-West G, Mittal KR, Muggia FM, Pothuri B (2016) Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndrome. Ecancermed Sci 18(10):613 Frey MK, David-West G, Mittal KR, Muggia FM, Pothuri B (2016) Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndrome. Ecancermed Sci 18(10):613
22.
go back to reference Lécuru F, Huchon C, Metzger U, Bats AS, Le Frère Belda MA, Olschwang S, Puig PL (2010) Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer/Lynch syndrome. Int J Gynecol Cancer 20(4):583–587CrossRefPubMed Lécuru F, Huchon C, Metzger U, Bats AS, Le Frère Belda MA, Olschwang S, Puig PL (2010) Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer/Lynch syndrome. Int J Gynecol Cancer 20(4):583–587CrossRefPubMed
23.
go back to reference Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit EF, Verheul HM, Noske DP, Reijneveld JC, Nilsson RJ, Tannous BA, Wesseling P, Wurdinger T (2015) RNA-seq of tumor-educated platelets enables blood-based pan-cancer. Multiclass and molecular pathway cancer diagnostics. Cancer Cell 28(5):666–676CrossRefPubMedPubMedCentral Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit EF, Verheul HM, Noske DP, Reijneveld JC, Nilsson RJ, Tannous BA, Wesseling P, Wurdinger T (2015) RNA-seq of tumor-educated platelets enables blood-based pan-cancer. Multiclass and molecular pathway cancer diagnostics. Cancer Cell 28(5):666–676CrossRefPubMedPubMedCentral
24.
go back to reference Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, Famuyide AO, Clayton AC, Halling KC, Kerr SE, Cliby WA, Dowdy SC, Kipp BR, Mariani A, Oberg AL, Podratz KC, Shridhar C, Sherman ME (2015) Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecol Oncol 137(1):14–22CrossRefPubMedPubMedCentral Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, Famuyide AO, Clayton AC, Halling KC, Kerr SE, Cliby WA, Dowdy SC, Kipp BR, Mariani A, Oberg AL, Podratz KC, Shridhar C, Sherman ME (2015) Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecol Oncol 137(1):14–22CrossRefPubMedPubMedCentral
Metadata
Title
Pain evaluation during gynaecological surveillance in women with Lynch syndrome
Authors
Jorien Helder-Woolderink
Geertruida de Bock
Harry Hollema
Magda van Oven
Marian Mourits
Publication date
01-04-2017
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 2/2017
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-016-9937-x

Other articles of this Issue 2/2017

Familial Cancer 2/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine